The University of Southampton
University of Southampton Institutional Repository

Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania

Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania
Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania
BACKGROUND: In HIV-1-infected women, poor micronutrient status has been associated with faster progression of HIV-1 disease and adverse birth outcomes. We assessed the effects of vitamin A and multivitamins on birth outcomes in such women.

METHODS: In Tanzania, 1075 HIV-1-infected pregnant women at between 12 and 27 weeks' gestation received placebo (n=267), vitamin A (n=269), multivitamins excluding vitamin A (n=269), or multivitamins including vitamin A (n=270) in a randomised, double-blind, placebo-controlled trial with a 2x2 factorial design. We measured the effects of multivitamins and vitamin A on birth outcomes and counts of T lymphocyte subsets. We did analyses by intention to treat.

RESULTS: 30 fetal deaths occurred among women assigned multivitamins compared with 49 among those not on multivitamins (relative risk 0.61 [95% CI 0.39-0.94] p=0.02). Multivitamin supplementation decreased the risk of low birthweight (<2500 g) by 44% (0.56 [0.38-0.82] p=0.003), severe preterm birth (<34 weeks of gestation) by 39% (0.61 [0.38-0.96] p=0.03), and small size for gestational age at birth by 43% (0.57 [0.39-0.82] p=0.002). Vitamin A supplementation had no significant effect on these variables. Multivitamins, but not vitamin A, resulted in a significant increase in CD4, CD8, and CD3 counts.

INTERPRETATION: Multivitamin supplementation is a low-cost way of substantially decreasing adverse pregnancy outcomes and increasing T-cell counts in HIV-1-infected women. The clinical relevance of our findings for vertical transmission and clinical progression of HIV-1 disease is yet to be ascertained.

PIP: Poor micronutrient status has been associated, in HIV-positive women, with faster progression of HIV disease and adverse birth outcomes. This randomized, double-blind, placebo-controlled study assessed the effects of vitamin A and multivitamins on birth outcomes in 1075 HIV-positive pregnant women at 12-27 weeks' gestation from Dar es Salaam, Tanzania. There were no differences in baseline plasma vitamin concentrations between groups. 267 women received a placebo, 269 were given vitamin A, 269 were administered a multivitamin excluding vitamin A, and 270 received a multivitamin including vitamin A. There were 30 fetal deaths in the group of women who received multivitamins (with and without vitamin A) compared with 49 among those not given multivitamins (relative risk (RR), 0.61; 95% confidence interval (CI), 0.39-0.94). Multivitamin supplementation decreased the risk of low birth weight (2500 g) by 44% (RR, 0.56; 95% CI, 0.38-0.82), of preterm birth (prior to 34 weeks gestation) by 39% (RR, 0.61; 95% CI, 0.38-0.96), and of small size for gestational age at birth by 43% (RR, 0.57; 95% CI, 0.39-0.82). Vitamin A had no significant effect on these variables. Multivitamins, but not vitamin A, were associated with significant increases in CD4, CD8, and CD3 counts. The clinical relevance of multivitamin supplementation for vertical transmission of HIV and the progression of disease remain unknown. However, these results indicate such supplementation is a low-cost means of substantially decreasing adverse pregnancy outcomes and increasing T cell counts in HIV-infected women. The observed beneficial effects of multivitamins on birth outcomes may have been mediated through improved maternal immune status.
0140-6736
1477-1482
Fawzi, W.W.
57972fc9-8504-42a1-9f9f-094942d11898
Msamanga, G.I.
d7825a8c-3340-40e5-aea5-a45dc8acb7ca
Spiegelman, D.
28eec24a-b7d7-49c5-89ec-61970196531b
Urassa, E.J.
613ecfff-fa52-4c19-9055-826bd6db0744
McGrath, N.
b75c0232-24ec-443f-93a9-69e9e12dc961
Mwakagile, D.
7b713c7c-d989-4d5d-a0f9-cb8a3b4a57fb
Antelman, G.
59a76c41-1d61-47b8-9bda-ad76132dc6ad
Mbise, R.
1dcfe9d3-d4ec-4d85-9f82-62acb42abac7
Herrera, G.
537f3c37-48a5-4a8d-acb7-7a3732fe9f95
Kapiga, S.
258e99cb-4793-4495-81b9-4c581670d82c
Willett, W.
f28518e9-389b-496a-b1b2-c156fdd4a26f
Hunter, D.J.
858ea3f1-f56d-4a1f-bac3-a82ca68e89e7
Fawzi, W.W.
57972fc9-8504-42a1-9f9f-094942d11898
Msamanga, G.I.
d7825a8c-3340-40e5-aea5-a45dc8acb7ca
Spiegelman, D.
28eec24a-b7d7-49c5-89ec-61970196531b
Urassa, E.J.
613ecfff-fa52-4c19-9055-826bd6db0744
McGrath, N.
b75c0232-24ec-443f-93a9-69e9e12dc961
Mwakagile, D.
7b713c7c-d989-4d5d-a0f9-cb8a3b4a57fb
Antelman, G.
59a76c41-1d61-47b8-9bda-ad76132dc6ad
Mbise, R.
1dcfe9d3-d4ec-4d85-9f82-62acb42abac7
Herrera, G.
537f3c37-48a5-4a8d-acb7-7a3732fe9f95
Kapiga, S.
258e99cb-4793-4495-81b9-4c581670d82c
Willett, W.
f28518e9-389b-496a-b1b2-c156fdd4a26f
Hunter, D.J.
858ea3f1-f56d-4a1f-bac3-a82ca68e89e7

Fawzi, W.W., Msamanga, G.I., Spiegelman, D., Urassa, E.J., McGrath, N., Mwakagile, D., Antelman, G., Mbise, R., Herrera, G., Kapiga, S., Willett, W. and Hunter, D.J. (1998) Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. The Lancet, 351 (9114), 1477-1482. (doi:10.1016/S0140-6736(98)04197-X). (PMID:9605804)

Record type: Article

Abstract

BACKGROUND: In HIV-1-infected women, poor micronutrient status has been associated with faster progression of HIV-1 disease and adverse birth outcomes. We assessed the effects of vitamin A and multivitamins on birth outcomes in such women.

METHODS: In Tanzania, 1075 HIV-1-infected pregnant women at between 12 and 27 weeks' gestation received placebo (n=267), vitamin A (n=269), multivitamins excluding vitamin A (n=269), or multivitamins including vitamin A (n=270) in a randomised, double-blind, placebo-controlled trial with a 2x2 factorial design. We measured the effects of multivitamins and vitamin A on birth outcomes and counts of T lymphocyte subsets. We did analyses by intention to treat.

RESULTS: 30 fetal deaths occurred among women assigned multivitamins compared with 49 among those not on multivitamins (relative risk 0.61 [95% CI 0.39-0.94] p=0.02). Multivitamin supplementation decreased the risk of low birthweight (<2500 g) by 44% (0.56 [0.38-0.82] p=0.003), severe preterm birth (<34 weeks of gestation) by 39% (0.61 [0.38-0.96] p=0.03), and small size for gestational age at birth by 43% (0.57 [0.39-0.82] p=0.002). Vitamin A supplementation had no significant effect on these variables. Multivitamins, but not vitamin A, resulted in a significant increase in CD4, CD8, and CD3 counts.

INTERPRETATION: Multivitamin supplementation is a low-cost way of substantially decreasing adverse pregnancy outcomes and increasing T-cell counts in HIV-1-infected women. The clinical relevance of our findings for vertical transmission and clinical progression of HIV-1 disease is yet to be ascertained.

PIP: Poor micronutrient status has been associated, in HIV-positive women, with faster progression of HIV disease and adverse birth outcomes. This randomized, double-blind, placebo-controlled study assessed the effects of vitamin A and multivitamins on birth outcomes in 1075 HIV-positive pregnant women at 12-27 weeks' gestation from Dar es Salaam, Tanzania. There were no differences in baseline plasma vitamin concentrations between groups. 267 women received a placebo, 269 were given vitamin A, 269 were administered a multivitamin excluding vitamin A, and 270 received a multivitamin including vitamin A. There were 30 fetal deaths in the group of women who received multivitamins (with and without vitamin A) compared with 49 among those not given multivitamins (relative risk (RR), 0.61; 95% confidence interval (CI), 0.39-0.94). Multivitamin supplementation decreased the risk of low birth weight (2500 g) by 44% (RR, 0.56; 95% CI, 0.38-0.82), of preterm birth (prior to 34 weeks gestation) by 39% (RR, 0.61; 95% CI, 0.38-0.96), and of small size for gestational age at birth by 43% (RR, 0.57; 95% CI, 0.39-0.82). Vitamin A had no significant effect on these variables. Multivitamins, but not vitamin A, were associated with significant increases in CD4, CD8, and CD3 counts. The clinical relevance of multivitamin supplementation for vertical transmission of HIV and the progression of disease remain unknown. However, these results indicate such supplementation is a low-cost means of substantially decreasing adverse pregnancy outcomes and increasing T cell counts in HIV-infected women. The observed beneficial effects of multivitamins on birth outcomes may have been mediated through improved maternal immune status.

This record has no associated files available for download.

More information

e-pub ahead of print date: 16 May 1998
Organisations: Faculty of Health Sciences

Identifiers

Local EPrints ID: 350544
URI: http://eprints.soton.ac.uk/id/eprint/350544
ISSN: 0140-6736
PURE UUID: fc5c08db-11e5-41a0-a74c-1503c45d7979
ORCID for N. McGrath: ORCID iD orcid.org/0000-0002-1039-0159

Catalogue record

Date deposited: 26 Mar 2013 14:21
Last modified: 16 Aug 2024 01:46

Export record

Altmetrics

Contributors

Author: W.W. Fawzi
Author: G.I. Msamanga
Author: D. Spiegelman
Author: E.J. Urassa
Author: N. McGrath ORCID iD
Author: D. Mwakagile
Author: G. Antelman
Author: R. Mbise
Author: G. Herrera
Author: S. Kapiga
Author: W. Willett
Author: D.J. Hunter

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×